Condition: Ocular Hypertension · Primary Open Angle Glaucoma · Sponsor: 59th Medical Wing
This randomized, single-masked, crossover, non-inferiority trial aims to evaluate the safety and efficacy of Nanodropper-mediated microdrops of ocular hypotensive topical treatments (experimental intervention) compared to standard drops of the same medication(s) (active comparator) in Wilford Hall Ambulatory Surgical Center (WHASC) primary open-angle glaucoma (POAG) and ocular hypertension (OHTN) patients.
This description comes directly from the study's public registry record.
Jose E Capo-Aponte, OD, PhD · 210-292-2554 · Jose.E.CapoAponte.ctr@health.mil
Jennifer Steger, PhD · 507-405-5676 · jenny@nanodropper.com
Always discuss trial participation with your own doctor first.
| Wilford Hall Ambulatory Surgical Center | Lackland Air Force Base, Texas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05844384